Alexion Pharmaceuticals, Inc.

NASDAQ: ALXN
$182.50
+$0.00 (+0.0%)
Closing Price on July 28, 2021

ALXN Articles

24/7 Wall St. has put together a preview of some of the world’s largest biotech and pharma companies reporting their earnings on Thursday.
The April 13 short interest data have been compared with the previous report, and moves in the selected biotech stocks were mixed.
The March 31 short interest data have been compared with the previous report, and short interest decreased in most of the selected biotech stocks.
The top analyst upgrades, downgrades and initiations include ConocoPhillips, Goodyear Tire, Humana, Lululemon Athletica and Range Resources.
The health care sector in general has rallied since Trump took over the presidency, but now that his repeal of the ACA fell through, the health care rally is called into question.
The February 28 short interest data have been compared with the previous report, and short interest decreased in most of the selected biotech stocks.
The February 15 short interest data have been compared with the previous report, and short interest increased in all the selected biotech stocks.
Alexion Pharmaceuticals released a mixed most recent earnings report before the markets opened on Thursday.
24/7 Wall St. has put together a preview of the most anticipated quarterly earnings reports that are on deck for Thursday.
24/7 Wall St. has put together a preview of Cisco, Pepsico and some of the other most anticipated quarterly earnings reports expected this coming week.
As we approached Trump’s inauguration, the health care sector in general rallied. Now it’s time to see what the bears have to say about this rally.
As we approached Trump’s inauguration, the health care sector in general rallied. Now it’s time to see what the bears have to say about this rally.
As we have approached Trump’s inauguration, the health care sector in general has rallied. Now it’s time to see what the bears have to say about this rally.
These are five top new picks that the JPMorgan team likes this month. All make good sense for growth portfolios.
As the markets are continuing to heat up, a few biopharma stocks made massive gains on Thursday. There is a very positive sentiment in the health care sector in anticipation of the new Trump...